LINC01702

Across TCGA pan-cancer cohorts, LINC01702 RNA differs between tumor and matched normal tissue in 8 of 18 cancer types tested, making tumor–normal expression one of LINC01702’s most consistent transcriptional readouts.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where LINC01702 RNA is repressed in tumor relative to normal tissue. In most cancer types LINC01702 is over-expressed in tumor, although a few such as KIRC and KIRP show the opposite, repressed pattern.

KIRC, KIRP, and KICH are the cancer types where LINC01702 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in LINC01702 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
KIRC	All	IV	−1.752	<.001	12	view →
KIRP	Male	III,IV	−2.401	<.001	11	view →
KICH	Male	II,III,IV	−2.921	<.001	10	view →
LIHC	Female	II,III,IV	−3.612	<.001	7	view →
CHOL	Female	All	−5.370	<.001	5	view →
LUAD	All	All	+0.167	.001	5	view →
LUSC	All	All	+0.099	.002	3	view →
HNSC	All	All	+0.114	.039	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 8 strongest of 8 lineages.

LINC01702–KIRC

Open the KIRC breakdown →